Turning Biological Complexity into R&D Advantage with Virtual Cells - with Giorgio Gaglia of Sanofi & Daniel Veres of Turbine

Artificial Intelligence in Industry with Dan Faggella by Daniel Faggella

Oct 5, 202631:46Technology

Drug discovery teams are running short of new ideas to test, and AI models that simulate how cells respond to drugs only pay off once leaders know when those predictions can be trusted with experiments, timelines, and bu...

Related Episodes

Continue listening to more episodes from Artificial Intelligence in Industry with Dan Faggella.

Intelligent Operations at Enterprise Scale - with Dhrubojyoti Das Deb of JPMorganChase

Oct 9, 2026 - 26:45

Alert volume inside IT operations has outpaced manual triage, leaving real incidents buried in noise. In...

What Shared Intelligence Really Fixes in Enterprise AI - with John McMullan of Observe.ai

Oct 8, 2026 - 27:33

Enterprise CX teams have poured budget into AI, yet many still can't show measurable returns — frontline...

Inside the Shift Toward Smarter Automated CX - with Paul Cuglietta of Simplyhealth

Oct 7, 2026 - 21:55

A single misstep in a new customer service channel can undo months of trust-building work. In this episod...

Stop Overpaying for AI Power You Don't Need - with Melissa Ramey of Salesforce

Oct 6, 2026 - 29:35

An AI agent can function as designed yet produce results an organization cannot verify or safely use. In...

Where AI Should Actually Earn Its Keep in Biopharma - with Mukhtar Ahmed of Greenstone Biosciences

Sep 29, 2026 - 22:14

In biopharma R&D, AI investment has overwhelmingly targeted generating more drug candidates, even though...

Modernizing Finance Data for Faster and More Reliable Operations - with Ciprian Porutiu of Marsh

Sep 24, 2026 - 26:18

Finance teams face immense pressure to operate faster, but rushing to automate over fragmented systems on...

Managing Change Across Modern Financial Operations - with Nathaniel Bell of Wells Fargo

Sep 22, 2026 - 22:00

For large banks, the barrier to AI at scale is rarely the model. It's decades of fragmented systems, inhe...

Transforming Cardiovascular Care — How AI-Driven Insights Unlock Value for Hospitals and Clinics - with Jim Hartman of Cleerly

Sep 17, 2026 - 26:46

Hospitals and clinics continue to face a central challenge: extensive cardiac testing still fails to deli...